- Home
- CRIS vs NTWK Comparison
CRIS vs NTWK Comparison
Compare CRIS & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | NTWK |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 35.5M |
| IPO Year | 2000 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CRIS | NTWK |
|---|---|---|
| Price | $1.18 | $3.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 114.9K | 48.6K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $11,650,000.00 | ★ $66,501,654.00 |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $8.44 | N/A |
| P/E Ratio | ★ N/A | $72.45 |
| Revenue Growth | ★ 13.56 | 7.70 |
| 52 Week Low | $1.02 | $2.14 |
| 52 Week High | $4.50 | $5.75 |
Technical Indicators
Market Signals| Indicator | CRIS | NTWK |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 50.13 |
| Support Level | $1.14 | $2.88 |
| Resistance Level | $1.41 | $3.05 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 27.10 | 78.43 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About NTWK NetSol Technologies Inc.
NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.